Boeing (BA)

Total Costs & Expenses

$99.08B

TTM · Period ending: · USD

BA logo

BA Total Costs & Expenses

Latest reported$99.08B
BA TTM Total Costs & Expenses ($16.34B → $99.08B)
High-resolution chart · PNG

BA total costs & expenses history

Trailing twelve months (TTM) · USD. Each value covers four complete reported quarters.

Boeing Total Costs & Expenses — Trailing twelve months (TTM) (USD)
Period endingTotal Costs & Expenses (USD)
99,078,000,000
97,613,000,000
94,879,000,000
89,181,000,000
84,718,000,000
79,657,000,000
77,277,000,000
79,947,000,000
75,258,000,000
77,152,000,000
78,567,000,000
77,165,000,000
77,001,000,000
73,052,000,000
70,135,000,000
68,766,000,000
64,967,000,000
65,041,000,000
65,188,000,000
69,577,000,000
69,168,000,000
67,964,000,000
70,925,000,000
67,687,000,000
71,868,000,000
76,228,000,000
78,534,000,000
82,585,000,000
86,783,000,000
89,200,000,000
89,140,000,000
87,312,000,000
85,986,000,000
84,959,000,000
84,207,000,000
82,972,000,000
82,995,000,000
87,648,000,000
88,737,000,000
90,046,000,000
91,699,000,000
89,385,000,000
88,671,000,000
88,702,000,000
87,098,000,000
84,496,000,000
83,289,000,000
83,116,000,000
81,778,000,000
81,619,000,000
80,061,000,000
78,464,000,000
76,586,000,000
74,950,000,000
75,403,000,000
72,688,000,000
70,252,000,000
66,798,000,000
62,890,000,000
60,379,000,000
59,946,000,000
59,203,000,000
59,335,000,000
60,132,000,000
63,391,000,000
64,750,000,000
66,185,000,000
62,848,000,000
58,155,000,000
58,245,000,000
56,959,000,000
60,013,000,000
60,885,000,000
60,692,000,000
60,557,000,000
60,985,000,000
59,755,000,000
59,267,000,000
58,516,000,000
55,787,000,000
53,591,000,000
52,423,000,000
51,112,000,000
50,738,000,000
51,787,000,000
50,365,000,000
50,450,000,000
49,680,000,000
48,797,000,000
49,382,000,000
49,931,000,000
50,077,000,000
50,447,000,000
50,000,000,000
50,201,000,000
52,996,000,000
53,489,000,000
55,056,000,000
54,302,000,000
52,826,000,000
Data is provided for informational purposes only and does not constitute investment advice. Past performance is not indicative of future results.